AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comNOV 33 min read$HSIC

Henry Schein’s (NASDAQ:HSIC) Q3 2026 earnings results: revenue in line with expectations

Henry Schein reported Q3 2026 revenue of $3.47B, matching estimates, and adjusted EPS of $1.56, beating estimates by 14.9%. Adjusted EBITDA was $321M, also a beat. Management raised full-year adjusted EPS guidance to $5.53. Organic revenue grew 3.1% year-on-year, missing expectations.

Original reporting
finance.yahoo.com
Published Nov 3, 2026, 11:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:51 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Henry Schein’s (NASDAQ:HSIC) Q3 2026 earnings results: revenue in line with expectations — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$HSICBullishMed
01

Why it matters

Raised full-year adjusted EPS guidance is the key incremental catalyst, while the organic revenue miss and flat free cash flow margin act as constraints on the bull case.

02

Market read

Traders can reassess valuation and positioning based on the guidance midpoint increase and the mix of beats versus the organic revenue miss.

03

What to watch

Free cash flow margin is described as flat versus last year, so investors may scrutinize whether earnings strength is translating into cash generation.

Relevance 8/10Novelty 7/10Timing: post-earnings, reported 2026-11-03

Background

The piece summarizes Henry Schein’s Q3 2026 results versus S&P analysts’ consensus and notes a full-year guidance increase.

Company-level read

Ticker impact

$HSICBullishHigh confidence
Context

Henry Schein reported Q3 revenue of $3.47B in line, but adjusted EPS and EBITDA beat consensus, and raised full-year adjusted EPS guidance to $5.53.

Expected impact

Likely upward bias as the market prices in higher full-year adjusted EPS, tempered by the organic revenue miss.

Evidence & confidence

The article contains multiple company-specific earnings datapoints plus a guidance raise, which are direct drivers of near-term repricing; the organic revenue miss is the main offset.

Market effects

Sector

Signals resilience in healthcare distribution/solutions demand, with margin support strong enough to offset slower organic revenue growth.

Regional

Primarily US-listed large-cap earnings read-through for healthcare services and distribution peers.

Global

Limited direct global spillover beyond investor sentiment toward US healthcare distributors.

Counterpoint

What could challenge this read

The guidance raise may not fully compensate for the organic revenue miss, suggesting the quality of growth is weaker than headline revenue implies.

Key entities

  • company
    Henry Schein

    Reported Q3 2026 revenue, adjusted EPS/EBITDA, and raised full-year adjusted EPS guidance.

Read at source← All news

StoryHenry Schein beats Q3 profit estimates and raises FY2026 guidance

Also covered by

5 outlets

Related articles

NOV 3
$HSICMedAI 8/10

What Henry Schein (HSIC) Said on Its Q3 Earnings Call

Henry Schein (HSIC) reported Q3 earnings, noting pressure in discretionary procedures but strong growth in global dental and specialty products. U.S. dental equipment sales rose 1.6%, while global distribution and value-added services increased 3.7%. The company raised its non-GAAP EPS outlook to $5.50-$5.56. Management expects 2026 sales growth of 4.5%-5.5% and high-single-digit adjusted EBITDA growth.

finance.yahoo.com6 min
NOV 3
$HSICMedAI 8/10

Henry Schein, Inc. Q3 2026 Earnings Call Summary

Henry Schein reported Q3 2026 US dental merchandise growth of 8.6%, driven by volume. The company targets $200M in operating income improvements by 2026, with $125M expected by year-end. Non-GAAP EPS guidance raised to $5.50–$5.56. Management expects double-digit EPS growth in 2027, supported by value creation initiatives and portfolio shifts. Q3 included a $0.19 per share tariff refund benefit and $22M in restructuring expenses. Emmanuel Capre will succeed Ronald South as CFO in November 2026.

finance.yahoo.com6 min
NOV 3
$HSICHighAI 8/10

HENRY SCHEIN REPORTS STRONG 2026 THIRD QUARTER AND RAISES FY2026 GUIDANCE

HENRY SCHEIN INC (HSIC) filed an SEC Form 8-K — Results of Operations and Financial Condition. -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS STRONG 2026 THIRD QUARTER AND RAISES FY2026 GUIDANCE ● Q3 2026 GAAP diluted EPS of $1.06, up 26.2% versus prior year; Q3 2026 non-GAAP diluted EPS of $1.56, up 13.0% versus prior year ● 4.0% total sales growth, driven by 8.6% U.

SEC EDGAR 8-K2 min
NOV 3
$HSICHighAI 8/10

Henry Schein Q3 Earnings, Sales Climb; Lifts 2026 Adj. Income Outlook

Henry Schein (HSIC) reported Q3 fiscal 2026 earnings of $1.06 per share, up from $0.84 a year ago, with adjusted profit at $1.37 per share. Revenue rose to $3.471 billion. The company raised its 2026 adjusted earnings outlook to $5.50-$5.56 per share, citing tariff refunds and improved performance. HSIC shares were down 0.14% pre-market.

rttnews.com1 min